- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting ubiquitination for cancer therapies
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 7, Issue 17, Pages 2333-2350
Publisher
Future Science, LTD
Online
2015-12-03
DOI
10.4155/fmc.15.148
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies
- (2015) L. F. Peterson et al. BLOOD
- Characterization and identification of ubiquitin conjugation sites with E3 ligase recognition specificities
- (2015) Van-Nui Nguyen et al. BMC BIOINFORMATICS
- Lenalidomide in multiple myeloma
- (2015) Young Kim et al. Expert Review of Anticancer Therapy
- E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma
- (2015) Kristina Bielskienė et al. Medicina-Lithuania
- Skp2-Dependent Ubiquitination and Activation of LKB1 Is Essential for Cancer Cell Survival under Energy Stress
- (2015) Szu-Wei Lee et al. MOLECULAR CELL
- Deubiquitinase inhibition as a cancer therapeutic strategy
- (2015) Padraig D'Arcy et al. PHARMACOLOGY & THERAPEUTICS
- E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma
- (2015) Kristina Bielskienė et al. Medicina-Lithuania
- Modulation of Immune Cell Functions by the E3 Ligase Cbl-b
- (2015) Christina Lutz-Nicoladoni et al. Frontiers in Oncology
- Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy
- (2014) Raymond J Deshaies BMC BIOLOGY
- Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer
- (2014) A. Pal et al. CANCER RESEARCH
- Skp2: A dream target in the coming age of cancer therapy
- (2014) Chia-Hsin Chan et al. CELL CYCLE
- E3 ubiquitin ligase Cbl-b in innate and adaptive immunity
- (2014) Liu Qingjun et al. CELL CYCLE
- Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma
- (2014) Lenka Kubiczkova et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
- (2014) Shaji K Kumar et al. LANCET ONCOLOGY
- USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses
- (2014) Qiang Zou et al. NATURE IMMUNOLOGY
- Ubiquitination in disease pathogenesis and treatment
- (2014) Doris Popovic et al. NATURE MEDICINE
- SCF ubiquitin ligase-targeted therapies
- (2014) Jeffrey R. Skaar et al. NATURE REVIEWS DRUG DISCOVERY
- New insights into ubiquitin E3 ligase mechanism
- (2014) Christopher E Berndsen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling
- (2014) Z Huang et al. ONCOGENE
- Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer
- (2013) Tom Van Maerken et al. CANCER LETTERS
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
- (2013) Chia-Hsin Chan et al. CELL
- Inhibition of Protein Deubiquitination by PR-619 Activates the Autophagic Pathway in OLN-t40 Oligodendroglial Cells
- (2013) Veronika Seiberlich et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Over-Expression of Deubiquitinating Enzyme USP14 in Lung Adenocarcinoma Promotes Proliferation through the Accumulation of β-Catenin
- (2013) Ning Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies
- (2013) Lindsey N. Micel et al. JOURNAL OF CLINICAL ONCOLOGY
- Exploring a New Frontier in Cancer Treatment: Targeting the Ubiquitin and Ubiquitin-like Activating Enzymes
- (2013) Sara R. da Silva et al. JOURNAL OF MEDICINAL CHEMISTRY
- A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation
- (2013) Bill B Chen et al. NATURE IMMUNOLOGY
- Mechanisms and function of substrate recruitment by F-box proteins
- (2013) Jeffrey R. Skaar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming
- (2013) Elena Maspero et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
- (2013) Julia S. Gelman et al. PLoS One
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Strategy for Modulation of Enzymes in the Ubiquitin System
- (2013) A. Ernst et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Linear ubiquitination: a newly discovered regulator of cell signalling
- (2013) Eva Rieser et al. TRENDS IN BIOCHEMICAL SCIENCES
- Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development
- (2013) Binh Vu et al. ACS Medicinal Chemistry Letters
- The Ubiquitin Code
- (2012) David Komander et al. Annual Review of Biochemistry
- The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: Implications for neurodegenerative diseases
- (2012) Veronika Seiberlich et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Ubiquitin-based anticancer therapy: Carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors
- (2012) Michael R. Mattern et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma
- (2012) R. Vij et al. BLOOD
- An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib
- (2012) Ravi Vij et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
- (2012) Chia-Hsin Chan et al. CELL
- Specific Small Molecule Inhibitors of Skp2-Mediated p27 Degradation
- (2012) Lily Wu et al. CHEMISTRY & BIOLOGY
- P53 Mdm2 Inhibitors
- (2012) Kareem Khoury et al. CURRENT PHARMACEUTICAL DESIGN
- Computational Prediction of Protein Hot Spot Residues
- (2012) John Kenneth Morrow et al. CURRENT PHARMACEUTICAL DESIGN
- MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
- (2012) Steffan T Nawrocki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- HECT and RING finger families of E3 ubiquitin ligases at a glance
- (2012) M. B. Metzger et al. JOURNAL OF CELL SCIENCE
- Manadosterols A and B, Sulfonated Sterol Dimers Inhibiting the Ubc13–Uev1A Interaction, Isolated from the Marine Sponge Lissodendryx fibrosa
- (2012) Shuntaro Ushiyama et al. JOURNAL OF NATURAL PRODUCTS
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
- (2012) A Lopez-Girona et al. LEUKEMIA
- Refined Preparation and Use of Anti-diglycine Remnant (K-ε-GG) Antibody Enables Routine Quantification of 10,000s of Ubiquitination Sites in Single Proteomics Experiments
- (2012) Namrata D. Udeshi et al. MOLECULAR & CELLULAR PROTEOMICS
- MDM4 is a key therapeutic target in cutaneous melanoma
- (2012) Agnieszka Gembarska et al. NATURE MEDICINE
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
- (2012) Pieter J A Eichhorn et al. NATURE MEDICINE
- Erioflorin Stabilizes the Tumor Suppressor Pdcd4 by Inhibiting Its Interaction with the E3-ligase β-TrCP1
- (2012) Johanna S. Blees et al. PLoS One
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts
- (2011) Cyrus Chargari et al. CANCER LETTERS
- An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme
- (2011) Derek F. Ceccarelli et al. CELL
- Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
- (2011) Mikael Altun et al. CHEMISTRY & BIOLOGY
- A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors
- (2011) J. Tabernero et al. CLINICAL CANCER RESEARCH
- Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
- (2011) B. C. Potts et al. CURRENT CANCER DRUG TARGETS
- Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function
- (2011) Avinash Persaud et al. EMBO JOURNAL
- Structure of the HECT:ubiquitin complex and its role in ubiquitin chain elongation
- (2011) Elena Maspero et al. EMBO REPORTS
- Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- Mechanism of Action of Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of Synergy in Multiple Myeloma
- (2011) T. Hideshima et al. MOLECULAR CANCER THERAPEUTICS
- USP15 is a deubiquitylating enzyme for receptor-activated SMADs
- (2011) Masafumi Inui et al. NATURE CELL BIOLOGY
- Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells
- (2011) Erika Suzuki et al. PLoS One
- Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
- (2010) R. T. Swords et al. BLOOD
- Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis
- (2010) V. Kapuria et al. CANCER RESEARCH
- Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
- (2010) E. Kupperman et al. CANCER RESEARCH
- Differential binding of p53 and nutlin to MDM2 and MDMX: Computational studies
- (2010) Thomas Leonard Joseph et al. CELL CYCLE
- Ubiquitin networks in cancer
- (2010) Vladimir Kirkin et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
- (2010) Lawrence R. Dick et al. DRUG DISCOVERY TODAY
- A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
- (2010) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14
- (2010) Byung-Hoon Lee et al. NATURE
- An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase
- (2010) Stephen Orlicky et al. NATURE BIOTECHNOLOGY
- Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase
- (2010) Mariam Aghajan et al. NATURE BIOTECHNOLOGY
- Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis
- (2010) Chia-Hsin Chan et al. NATURE CELL BIOLOGY
- Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development
- (2010) W-L Yang et al. ONCOGENE
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Pomalidomide: A new IMiD with remarkable activity in both multiple myeloma and myelofibrosis
- (2009) Martha Q. Lacy et al. AMERICAN JOURNAL OF HEMATOLOGY
- RING Domain E3 Ubiquitin Ligases
- (2009) Raymond J. Deshaies et al. Annual Review of Biochemistry
- The multiple levels of regulation by p53 ubiquitination
- (2009) J T Lee et al. CELL DEATH AND DIFFERENTIATION
- Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells
- (2009) Fenghua Zeng et al. FASEB JOURNAL
- Absolute Configuration of the α,ω-Bifunctionalized Sphingolipid Leucettamol A fromLeucetta microrhaphisby Deconvoluted Exciton Coupled CD⊥
- (2009) Doralyn S. Dalisay et al. JOURNAL OF NATURAL PRODUCTS
- Nonproteolytic Functions of Ubiquitin in Cell Signaling
- (2009) Zhijian J. Chen et al. MOLECULAR CELL
- Targeting the ubiquitin system in cancer therapy
- (2009) Daniela Hoeller et al. NATURE
- Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB
- (2009) Hui-Kuan Lin et al. NATURE CELL BIOLOGY
- Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways
- (2009) Brenda A. Schulman et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Physiological functions of the HECT family of ubiquitin ligases
- (2009) Daniela Rotin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Breaking the chains: structure and function of the deubiquitinases
- (2009) David Komander et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A novel small-molecule inhibitor of NF-κB signaling
- (2008) Hiroto Nakajima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Leucettamol A: A new inhibitor of Ubc13-Uev1A interaction isolated from a marine sponge, Leucetta aff. microrhaphis
- (2008) Sachiko Tsukamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy
- (2008) Q. Chen et al. BLOOD
- Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer
- (2008) Dan D. Hershko CANCER
- Targeting the ubiquitin-proteasome system for cancer therapy
- (2008) Yili Yang et al. CANCER SCIENCE
- Identification of SCF Ubiquitin Ligase Substrates by Global Protein Stability Profiling
- (2008) H.-C. S. Yen et al. SCIENCE
- Global Protein Stability Profiling in Mammalian Cells
- (2008) H.-C. S. Yen et al. SCIENCE
- Targeting ubiquitin specific proteases for drug discovery
- (2007) Laurent Daviet et al. BIOCHIMIE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now